Stockscreener 앱 받기
11.99
1.27%
0.15
시간 외 거래:
12.13
0.14
+1.17%
전일 마감가:
$11.84
열려 있는:
$11.93
하루 거래량:
5.13M
Relative Volume:
0.90
시가총액:
$8.19B
수익:
$125.68M
순이익/손실:
$4.81B
주가수익비율:
2.1221
EPS:
5.65
순현금흐름:
$-781.21M
1주 성능:
+2.30%
1개월 성능:
+3.81%
6개월 성능:
+15.51%
1년 성능:
+1.18%
1일 변동 폭
$11.87
$12.18
1주일 범위
$11.54
$12.18
52주 변동 폭
$8.73
$13.05
Roivant Sciences Ltd Stock (ROIV) Company Profile
명칭
Roivant Sciences Ltd
전화
441-295-5950
주소
7TH FLOOR, 50 BROADWAY, LONDON
ROIV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ROIV
Roivant Sciences Ltd
|
11.99 | 8.09B | 125.68M | 4.81B | -781.21M | 5.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 재개 | Goldman | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2024-01-05 | 개시 | Piper Sandler | Overweight |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-10-17 | 개시 | Guggenheim | Buy |
| 2023-06-08 | 개시 | BofA Securities | Neutral |
| 2022-10-27 | 개시 | JP Morgan | Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2022-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-12-15 | 개시 | Goldman | Buy |
| 2021-11-08 | 개시 | H.C. Wainwright | Buy |
| 2021-10-28 | 개시 | Citigroup | Buy |
| 2021-10-26 | 개시 | Cowen | Outperform |
| 2021-10-26 | 개시 | Jefferies | Buy |
| 2021-10-26 | 개시 | Truist | Buy |
모두보기
Roivant Sciences Ltd 주식(ROIV)의 최신 뉴스
Can volume confirm reversal in Roivant Sciences Ltd.Trade Analysis Report & Community Consensus Trade Signals - Newser
Is Roivant Sciences Ltd. forming a reversal pattern2025 Market Sentiment & Community Driven Trade Alerts - Newser
How high can Roivant Sciences Ltd. stock go2025 Price Targets & Long-Term Investment Growth Plans - Newser
Can a trend reversal in Roivant Sciences Ltd. lead to recoveryLayoff News & Weekly Top Stock Performers List - Newser
Measuring Roivant Sciences Ltd.’s beta against major indicesJuly 2025 Earnings & Reliable Trade Execution Plans - Newser
What candlestick patterns are forming on Roivant Sciences Ltd.July 2025 Momentum & Short-Term High Return Strategies - Newser
Analyzing Roivant Sciences Ltd. with risk reward ratio chartsGap Down & Weekly Watchlist for Hot Stocks - Newser
Applying Elliott Wave Theory to Roivant Sciences Ltd.Earnings Risk Report & Community Verified Swing Trade Signals - Newser
How to escape a deep drawdown in Roivant Sciences Ltd.July 2025 Big Picture & Technical Pattern Recognition Alerts - Newser
Analyzing Roivant Sciences Ltd. with multi timeframe chartsWeekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - Newser
How hedge fund analytics apply to Roivant Sciences Ltd. stockEarnings Overview Summary & Consistent Growth Stock Picks - Newser
Combining price and volume data for Roivant Sciences Ltd.Weekly Earnings Recap & AI Enhanced Trading Signals - Newser
Technical analysis overview for Roivant Sciences Ltd. stockLayoff News & Verified Short-Term Plans - Newser
Roivant Sciences Ltd. stock daily chart insightsSwing Trade & Weekly Watchlist for Hot Stocks - Newser
Roivant Sciences Ltd. Price Targets Raised After Rebound getLinesFromResByArray error: size == 0 - 더경남뉴스
How to use Fibonacci retracement on Roivant Sciences Ltd.July 2025 Big Picture & Safe Entry Momentum Tips - Newser
Published on: 2025-08-26 10:23:34 - Newser
Published on: 2025-08-26 09:26:04 - Newser
News impact scoring models applied to Roivant Sciences Ltd.2025 Volatility Report & Community Shared Stock Ideas - Newser
How to build a custom watchlist for Roivant Sciences Ltd.July 2025 Recap & Low Risk Growth Stock Ideas - Newser
What to do if you’re stuck in Roivant Sciences Ltd.Quarterly Risk Review & High Win Rate Trade Alerts - Newser
How to manage a losing position in Roivant Sciences Ltd.M&A Rumor & Safe Entry Point Identification - Newser
Forecasting Roivant Sciences Ltd. price range with options dataProfit Target & Technical Pattern Based Signals - Newser
Applying Wyckoff theory to Roivant Sciences Ltd. stockDay Trade & AI Powered Market Trend Analysis - Newser
Roivant Sciences Ltd. Shows Risk Reward Favoring UpsideQuarterly Trade Summary & Stepwise Trade Execution Plans - 더경남뉴스
Can trapped investors hope for a rebound in Roivant Sciences Ltd.New Guidance & Safe Entry Point Alerts - Newser
Insider Trading and Investment Implications at Roivant Sciences: Assessing Executive Liquidity Events and Their Impact on Investor Confidence - AInvest
Should you hold or exit Roivant Sciences Ltd. nowWeekly Trade Review & Reliable Trade Execution Plans - Newser
Chart overlay techniques for tracking Roivant Sciences Ltd.Index Update & Reliable Intraday Trade Plans - Newser
Live market analysis of Roivant Sciences Ltd.Earnings Beat & Daily Market Momentum Tracking - Newser
Will Roivant Sciences Ltd. announce a stock splitJuly 2025 Selloffs & Reliable Volume Spike Alerts - theviewers.co.kr
Will Roivant Sciences Ltd. rebound enough to break evenTrade Analysis Report & Fast Momentum Entry Tips - Newser
Will Roivant Sciences Ltd. outperform the marketJuly 2025 Earnings & Expert Verified Movement Alerts - Newser
Published on: 2025-08-21 19:14:30 - Newser
Earnings call transcript: Roivant Sciences Misses Q1 2026 EPS, Revenue Forecasts - Investing.com
Will Breakout in Roivant Sciences Ltd. Sustain Through Next Week2025 Buyback Activity & Free Community Consensus Stock Picks - 더경남뉴스
Machine Learning Models Forecast Roivant Sciences Ltd. Uptick2025 Short Interest & Weekly High Conviction Trade Ideas - newsimpact.co.kr
Roivant plans $500M new share repurchase as brepocitinib data readout nears - MSN
Is It Too Late to Sell Roivant Sciences Ltd.2025 Risk Factors & Free Risk Controlled Daily Trade Plans - newsimpact.co.kr
Roivant Sciences Ltd (ROIV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.98%
8.06%
자본화:
|
볼륨(24시간):